Journal of Biomedical Science

, Volume 7, Issue 3, pp 173–174 | Cite as

Biomedical vignette



  1. 1.
    Ballantyne JC, Loach AB, Carr DB. Itching after epidural and spinal opiates. Pain 33:149–160;1988.CrossRefGoogle Scholar
  2. 2.
    Chen L, Gu Y, Huang L-YM. The mechanism of action for the block of NMDA receptor channels by opioid peptide dynorphin. J Neurosci 15:4602–4611;1995.Google Scholar
  3. 3.
    Chiou LC. Pharmacological characterization of the nociceptin receptor, ORL1. J Biomed Sci 7:232–240;2000.CrossRefGoogle Scholar
  4. 4.
    Connor M, Schuller A, Pintar JE, Christie MJ. Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. Br J Pharmacol 126;1553–1558;1999.CrossRefPubMedGoogle Scholar
  5. 5.
    Dun NJ, Dun SL, Wu SY, Williams CA, Kwok EH. Endomorphins: Localization, release and action on rat dorsal horn neurons. J Biomed Sci 7:213–220;2000.CrossRefGoogle Scholar
  6. 6.
    Gon J, Strong JA, Zhang S, Yue X, DeHaven RN, Daubert JD, Cassel JA, Yu G, Mansson E, Yu L. Endomorphins fully activate a cloned human mu opioid receptor. FEBS Lett 439:152–156;1998.Google Scholar
  7. 7.
    Guerrini R, Calo G, Rizzi A, Bigoni R, Bianchi C, Salvadori S, Regoli D. A new selective antagonist of the nociceptin receptor. Br J Pharmacol 123:163–165;1998.CrossRefGoogle Scholar
  8. 8.
    Guo H, Enters EK, McDowell KP, Robinson SE. The effect of prenatal exposure to methadone on neurotransmitters in neonatal rats. Dev Brain Res 57:296–298;1990.CrossRefGoogle Scholar
  9. 9.
    Hackler L, Zadina JE, Ge LJ, Kastin AJ. Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex. Peptides 18:1635–1639;1997.CrossRefGoogle Scholar
  10. 10.
    Inturrisi CE, Max MB, Foley KM, Schultz M, Shin S-U, Houde RW. The pharmacokinetics of heroin in patients with chronic pain. N Eng J Med 310:1213–1217;1984.Google Scholar
  11. 11.
    Inturrisi CE, Schultz M, Shin S-U, Umans JG, Angel L, Simon EJ. Evidence from opiate binding studies that heroin acts through its metabolites. Life Sci 3:773–776;1983.CrossRefGoogle Scholar
  12. 12.
    Javis MAE, Schnoll SH. Methadone treatment during pregnancy. J Psychoactive Drugs 26:155–161;1994Google Scholar
  13. 13.
    Kong LY, McMillian MK, Hudson PM, Lin L, Hong J-S. Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures. J Pharmacol Exp Ther 280:61–66;1997.Google Scholar
  14. 14.
    Kong LY, Jeohn GE, Hudson PM, Du L, Liu B, Hong JS. Reduction of lipopolysaccharide-induced neurotoxicity in mouse mixed cortical neuron/glia cultures by ultralow concentration of dynorphins. J Biomed Sci 7:241–247;2000.PubMedGoogle Scholar
  15. 15.
    Kuraishi Y, Yamaguchi T, Miyamoto T. Itch-scratch responses induced by opioids through central μ-opioid receptors in mice. J Biomed Sci 7:248–252;2000.CrossRefPubMedGoogle Scholar
  16. 16.
    La P-Y. G-proteins and opioid receptors' function, In: Iseng LF, ed. The Pharmacology of Opioid Peptides. Amsterdam, Harwood Academic Publishers 109–130;1995.Google Scholar
  17. 17.
    Liu N, Rockhold RW, Ho IK. Electrical stimulation of nucleus paragigantocellularis induces opioid withdrawal-like behavior in the rat. Pharmacol Biochem Beh 62:263–271;1999.Google Scholar
  18. 18.
    Maldonado R. Participation of noradrenergic pathways in the expression of opiate withdrawal: Biochemical and pharmacological evidence. Neurosci Biobehav Rev 21:91–104;1997.Google Scholar
  19. 19.
    Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G, Meunier JC. ORL1, a novel member of the opioid receptor family: Cloning, functional expression and localization. FEBS Lett 341:33–38;1994.PubMedGoogle Scholar
  20. 20.
    Narita M, Mizoguchi H, Narita M, Dun NJ, Hwang BH, Endoh T, Suzuki T, Nagase H, Suzuki T, Tseng LF. G-protein activation by endomorphins in the mouse periaqueductal gray matter. J Biomed Sci 7:221–225;2000.PubMedGoogle Scholar
  21. 21.
    Rady JJ, Fujimoto JM. Acute cross tolerance to opioids in heroin δ-opioid responding Swiss Webster mice. J Biomed Sci 7:258–269;2000.PubMedGoogle Scholar
  22. 22.
    Reinscheid RK, Nothacker H-P, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ, Civelli O. Orphanin FQ: A novel neuropeptide which is a natural ligand of an opioid-like G protein-coupled receptor. Science 270:762–764;1995.Google Scholar
  23. 23.
    Robinson SE. The effect of prenatal opioid exposure on cholinergic development. J Biomed Sci 7:253–257;2000.Google Scholar
  24. 24.
    Rockhold RW, Liu N, Coleman D, Commiskey S, Shook J, Ho IK. The nucleus paragigantocellularis and opioid withdrawal-like behavior. J Biomed Sci 7:270–275;2000.PubMedGoogle Scholar
  25. 25.
    Simon EJ. Recent studies on opioid receptors: Heterogeneity and purification. Ann NY Acad Sci 463:31–35;1986.PubMedGoogle Scholar
  26. 26.
    Wu SY, Dun SL, Wright MT, Chang JK, Dun NJ. Endomorphin-like immunoreactivity in the rat dorsal horn and inhibition of substantia gelatinosa neurons in vitro. Neuroscience 89:317–321:1999.CrossRefGoogle Scholar
  27. 27.
    Yajiri Y, Huang LYM. Action of endomorphins on synaptic transmission of A δ-fibers in spinal cord dorsal horn neurons. J Biomed Sci 7:226–231:2000.CrossRefPubMedGoogle Scholar
  28. 28.
    Yaksh TL, Harty GJ, Onofrio BM. High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: Clinical and theoretic implications. Anesthesiology 19:590–597;1986.Google Scholar
  29. 29.
    Zadina JE, Hackler L, Ge L-J, Kastin AJ. A potent and selective endogenous agonist for the μ-opiate receptor. Nature 386:499–502;1997.CrossRefPubMedGoogle Scholar

Copyright information

© National Science Council 2000

Personalised recommendations